We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Renal Cell Carcinoma

Journal Scan / Research · September 08, 2021

Adjuvant TKI Therapy for Localized and Locally Advanced RCC

Urologic Oncology: Seminars and Original Investigations


Additional Info

Urologic Oncology: Seminars and Original Investigations
Adjuvant Therapy With Tyrosine Kinase Inhibitors for Localized and Locally Advanced Renal Cell Carcinoma: An Updated Systematic Review and Meta-Analysis
Urol. Oncol 2021 Aug 14;[EPub Ahead of Print], E Laukhtina, F Quhal, K Mori, R Sari Motlagh, B Pradere, VM Schuettfort, H Mostafaei, S Katayama, NС Grossmann, P Rajwa, I Resch, D Enikeev, PI Karakiewicz, SF Shariat, M Schmidinger

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading